Spencer Pharmaceutical Inc. (SPPH)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 27, 2025
0.00%
Market Cap 271.00
Revenue (ttm) n/a
Net Income (ttm) -943.20K
Shares Out 271.27M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 20,175
Open 0.0000
Previous Close 0.0000
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0000
Beta 25.77
RSI 41.01
Earnings Date n/a

About Spencer Pharmaceutical

Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, ... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1998
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol SPPH
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.